Biotech Lab 4.0
Vaccine development by design
A revolutionary way to accelerate, control and implement processes in real time by creating intelligent networks of equipment and open data systems that govern each other.
AchilleS Vaccines Biotech Lab 4.0 is a new model of early stage development for new biopharmaceutical products, particularly those containing, or consisting of, recombinant proteins (e.g. vaccines, immuno-therapeutics, ), and a new model of pre-clinical R&D.
Our Technology
AchilleS Vaccines exploits integrated technological platforms to identify, select and develop future approaches to deliver effective products.
They Talk About Us
Latest News
-
Penta Teams Up with IAVI and Achilles Vaccines to Develop New Treatments for HIV, Emerging Infections and Neglected Diseases
Padova, Italy, 01/02/2024 – Penta - Child Health Research announced a new collaboration with IAVI and Achilles Vaccines to accelerate the development of treatments for
-
InSilicoTrials and AchilleS Vaccines Join Forces to Create Next-Generation Vaccines and Monoclonal Antibodies against infectious Diseases
InSilicoTrials and AchilleS Vaccines have announced a strategic alliance that aims to unite visions, skills, experiences, the multidisciplinary collaboration network and interested institutions to accelerate
-
Progetto SHASI – Intelligenza artificiale per nuovi vaccini
Siena, 04/03/2022. Intelligenza artificiale per nuovi vaccini. È questo il tema del progetto SHASI (Siena Hub Against Salmonella Infections), che si è concluso lunedì 28